IL40904A - 2,4(or 2,5)disubstituted-4(or 5)oxazole carboxamides - Google Patents

2,4(or 2,5)disubstituted-4(or 5)oxazole carboxamides

Info

Publication number
IL40904A
IL40904A IL40904A IL4090472A IL40904A IL 40904 A IL40904 A IL 40904A IL 40904 A IL40904 A IL 40904A IL 4090472 A IL4090472 A IL 4090472A IL 40904 A IL40904 A IL 40904A
Authority
IL
Israel
Prior art keywords
disubstituted
carboxamides
oxazole
oxazole carboxamides
Prior art date
Application number
IL40904A
Other languages
English (en)
Other versions
IL40904A0 (en
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL40904A0 publication Critical patent/IL40904A0/xx
Publication of IL40904A publication Critical patent/IL40904A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
IL40904A 1972-08-07 1972-11-22 2,4(or 2,5)disubstituted-4(or 5)oxazole carboxamides IL40904A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (2)

Publication Number Publication Date
IL40904A0 IL40904A0 (en) 1973-01-30
IL40904A true IL40904A (en) 1975-12-31

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40904A IL40904A (en) 1972-08-07 1972-11-22 2,4(or 2,5)disubstituted-4(or 5)oxazole carboxamides

Country Status (23)

Country Link
JP (1) JPS5030619B2 (xx)
KR (1) KR780000069B1 (xx)
AR (1) AR200007A1 (xx)
AT (1) AT322551B (xx)
AU (1) AU477231B2 (xx)
BE (1) BE794096A (xx)
CH (1) CH544105A (xx)
CS (1) CS177127B2 (xx)
DD (1) DD106387A5 (xx)
DE (1) DE2301030A1 (xx)
ES (1) ES417638A1 (xx)
FR (1) FR2195430B1 (xx)
GB (1) GB1374345A (xx)
HU (1) HU164781B (xx)
IE (1) IE36941B1 (xx)
IL (1) IL40904A (xx)
LU (1) LU66643A1 (xx)
NL (1) NL149797B (xx)
NO (1) NO137550C (xx)
RO (1) RO63442A (xx)
SE (1) SE376236B (xx)
SU (1) SU511003A3 (xx)
ZA (1) ZA728259B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (xx) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) * 1983-02-10 1984-08-24 マルヤス機械株式会社 組立ライン装置
DE3425118A1 (de) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
JPS6133499U (ja) * 1984-07-30 1986-02-28 中西金属工業株式会社 電気製品製造用パレツト
CA2396738C (en) * 1990-11-30 2006-08-29 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
US8946231B2 (en) 2009-03-23 2015-02-03 Merck Sharp & Dohme Corp. P2X3, receptor antagonists for treatment of pain
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
EP2634185B1 (en) 2012-03-02 2016-01-13 Sareum Limited TYK2 kinase inhibitors
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (xx) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd

Also Published As

Publication number Publication date
NO137550C (no) 1978-03-15
NO137550B (no) 1977-12-05
NL149797B (nl) 1976-06-15
FR2195430B1 (xx) 1976-04-09
BE794096A (fr) 1973-05-16
JPS5030619B2 (xx) 1975-10-02
JPS4945067A (xx) 1974-04-27
SE376236B (xx) 1975-05-12
GB1374345A (en) 1974-11-20
KR780000069B1 (en) 1978-03-30
AU477231B2 (en) 1976-10-21
FR2195430A1 (xx) 1974-03-08
ZA728259B (en) 1973-07-25
IL40904A0 (en) 1973-01-30
AU5698273A (en) 1974-12-19
DE2301030A1 (de) 1974-02-28
AT322551B (de) 1975-05-26
DD106387A5 (xx) 1974-06-12
IE36941B1 (en) 1977-03-30
HU164781B (xx) 1974-04-11
SU511003A3 (ru) 1976-04-15
IE36941L (en) 1974-02-07
NL7300326A (xx) 1974-02-11
AR200007A1 (es) 1974-10-15
ES417638A1 (es) 1976-02-01
RO63442A (fr) 1978-07-15
CS177127B2 (xx) 1977-07-29
LU66643A1 (xx) 1973-02-14
CH544105A (fr) 1973-11-15

Similar Documents

Publication Publication Date Title
MY7900243A (en) Substituted 16,17,18,19,20-pentanor-prostaglandins
KE2670A (en) 1,2,3,-thiadiazole derivatives
IL40904A (en) 2,4(or 2,5)disubstituted-4(or 5)oxazole carboxamides
GB1406961A (en) 2,4,7-trioxopteridine derivatives
IL38936A (en) 1,6-dimethyl-10alpha-methoxy-8beta-pyrroyloxymethyl-ergolines
ZA727046B (en) 1,4-bis-acypiperazines
CA1000274A (en) Diacyl-5,6,11,12-tetrahydro-dibenzo(b,f) (1,4) diazocines
GB1402046A (en) 11,12-epoxyerythromycins
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
CA1024149A (en) 4.alpha.-ARYL-TRANS-DECAHYDROISOQUINOLINES
GB1373077A (en) Benzo-1,3,2-dioxapholphole derivatives
HK15179A (en) 2,6-diaminoneburlarine derivatives
AU6346873A (en) 1,2-dichloroethane
GB1404277A (en) 16,17-seco-d-homosteroids
AU5759173A (en) 1,2,4-oxadiazole derivatives
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
AU472337B2 (en) 11, 12-secoprostaglandins
ZA733182B (en) 10,11-anhydroerythromycins
ZA731789B (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
ZA738077B (en) 3,4-dihydro-2h-pyrane-2,4-diones
ZA733990B (en) Beta(3,4-dialkanyloxyphenyl)-l-alanines
ZA722183B (en) 1,2-biguanides
PH9820A (en) 3,6-disubstituted-29-dioxothiazolo-(5,4-f)quinoline-8-carboxylate
CA906488A (en) 12-substituted-11,12-dihydro-6h-di-benz(b,f) (1,4)oxazocines